Inventor · disambiguated record
Kenneth Loveday
Also filed as: LOVEDAY KENNETH · LOVEDAY KENNETH SWOPE
5 granted patents·4 pending applications·26 citations·filing 2003–2025
77Inventor score
Top patents by PatentIndex Score
9 records- 0192US7833742B2Treatment of α-galactosidase A deficiencySHIRE HUMAN GENETIC THERAPIES·Filed 2006·Granted Nov 16, 2010·21 cites·26 claims
- 0283US9523113B2Treatment of α-galactosidase A deficiencySHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Dec 20, 2016·3 cites·17 claims
- 0375US2024318182A1Methods of treating or preventing spinal muscular atrophyBIOGEN MA INC·Filed 2024·Application pending·0 cites
- 0473US9267166B2Treatment of α-galactosidase A deficiencyTRECO DOUGLAS A·Filed 2010·Granted Feb 23, 2016·2 cites·23 claims
- 0572US11116823B2Treatment of α-galactosidase a deficiencyTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 14, 2021·0 cites·25 claims
- 0670US2025230440A1Methods of treating or preventing spinal muscular atrophyBIOGEN MA INC·Filed 2025·Application pending·0 cites
- 0762US10245304B2Treatment of alpha-galactosidase a deficiencySHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Apr 2, 2019·0 cites·20 claims
- 0855US2022325282A1Methods of treating or preventing spinal muscular atrophyBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 0954US2004071686A1Treatment of alpha-galactosidase A deficiencyFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth Loveday files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →